close Video

NEW You can now listen to Fox News articles!

GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — were originally intended to treat type 2 diabetes and obesity.

But in recent months, studies have shown that these popular medications can have numerous other health benefits.

Some have even claimed that GLP-1s could eventually become the new "everything drug."

MEDITERRANEAN DIET PAIRED WITH OTHER LIFESTYLE CHANGES SLASHES DIABETES RISK

Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a "weight-inclusive" healthcare company based in Boston, said she would caution against labeling any medication as an "everything drug," but agrees that GLP-1s show promise.

"GLP-1s are currently approved for t

See Full Page